ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing... Show more
PRPH is expected to report earnings to fall 15.38% to -10 cents per share on November 06
Q3'25
Est.
$-0.11
Q1'25
Beat
by $0.05
Q4'24
Missed
by $1.62
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.25
The last earnings report on May 20 showed earnings per share of -12 cents, beating the estimate of -18 cents. With 373.88K shares outstanding, the current market capitalization sits at 12.97M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRPH showed earnings on May 20, 2025. You can read more about the earnings report here.